Previously, we demonstrated that high expression of IGF1 was closely associated with the maintenance of stemness in oxaliplatin-resistant HCC cells and that IGF1-IGF1R signaling blockade effectively increased oxaliplatin sensitivity [3]. This evidence concerns the gene IGF1 and hepatocellular carcinoma.